Nature Medicine, ISSN 1078-8956, 01/2019, Volume 25, Issue 1, pp. 165 - 175
Defective brain hormonal signaling has been associated with Alzheimer’s disease (AD), a disorder characterized by synapse and memory failure. Irisin is an...
Potentiation | Physical exercise | Neuroprotection | Brain | Animal models | Long-term potentiation | Memory | Impairment | Cerebrospinal fluid | Pattern recognition | Object recognition | Fibronectin | Membrane proteins | Proteins | Plasticity (synaptic) | Plasticity | Mice | Alzheimer's disease | Hippocampus | FNDC5 | memory | synaptic plasticity | Alzheimer’s disease | irisin | physical exercise
Potentiation | Physical exercise | Neuroprotection | Brain | Animal models | Long-term potentiation | Memory | Impairment | Cerebrospinal fluid | Pattern recognition | Object recognition | Fibronectin | Membrane proteins | Proteins | Plasticity (synaptic) | Plasticity | Mice | Alzheimer's disease | Hippocampus | FNDC5 | memory | synaptic plasticity | Alzheimer’s disease | irisin | physical exercise
Journal Article
European Polymer Journal, ISSN 0014-3057, 10/2018, Volume 107, p. 189
Nanocomposites based on poly(ethylene terephthalate-ethylene dilinoleate) (PET-DLA) copolymers of different hard to soft segment ratios (40:60 and 60:40) and...
Biological properties | Fourier transforms | Nuclear magnetic resonance--NMR | Ethylene | Segments | Impact analysis | Polyesters | Fibroblasts | Biocompatibility | Carbon fiber reinforced plastics | Polymers | Multi wall carbon nanotubes | High aspect ratio | Scanning electron microscopy | Cold crystallization | Carbon black | Fillers | Crystallization | Tensile tests | Mechanical properties | Polyethylene terephthalate | Modulus of elasticity | Carbon | Organic chemistry | Terephthalate | Nanocomposites | Graphene | Viability
Biological properties | Fourier transforms | Nuclear magnetic resonance--NMR | Ethylene | Segments | Impact analysis | Polyesters | Fibroblasts | Biocompatibility | Carbon fiber reinforced plastics | Polymers | Multi wall carbon nanotubes | High aspect ratio | Scanning electron microscopy | Cold crystallization | Carbon black | Fillers | Crystallization | Tensile tests | Mechanical properties | Polyethylene terephthalate | Modulus of elasticity | Carbon | Organic chemistry | Terephthalate | Nanocomposites | Graphene | Viability
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2008, Volume 105, Issue 20, pp. 7327 - 7332
Although deficiencies in the retromer sorting pathway have been linked to late-onset Alzheimer's disease, whether these deficiencies underlie the disease...
Receptors | Animal models | Nervous system diseases | Disease models | Neurodegenerative diseases | Humans | Antibodies | Mice | Amyloids | Alzheimers disease | Pathophysiology | Flies | flies | INHIBITION | TRANSGENIC MODELS | MULTIDISCIPLINARY SCIENCES | pathophysiology | IN-VIVO | PLAQUE-FORMATION | AMYLOID PRECURSOR PROTEIN | mice | EXPRESSION | RECEPTOR LR11 | Biological Sciences
Receptors | Animal models | Nervous system diseases | Disease models | Neurodegenerative diseases | Humans | Antibodies | Mice | Amyloids | Alzheimers disease | Pathophysiology | Flies | flies | INHIBITION | TRANSGENIC MODELS | MULTIDISCIPLINARY SCIENCES | pathophysiology | IN-VIVO | PLAQUE-FORMATION | AMYLOID PRECURSOR PROTEIN | mice | EXPRESSION | RECEPTOR LR11 | Biological Sciences
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 12/2008, Volume 28, Issue 53, pp. 14537 - 14545
Amyloid-beta (A beta) peptides are produced in high amounts during Alzheimer's disease, causing synaptic and memory dysfunction. However, they are also...
Amyloid-β | α-7 nicotinic receptors | Alzheimer's disease | Memory | Hippocampus | Synaptic plasticity | alpha-7 nicotinic receptors | APP | memory | hippocampus | ALZHEIMERS-DISEASE | INTERSTITIAL FLUID | NICOTINIC ACETYLCHOLINE-RECEPTORS | NEUROSCIENCES | amyloid-beta | SECRETED FORMS | IN-VIVO | synaptic plasticity | PRECURSOR PROTEIN | SHORT-TERM | BRAIN | TRANSGENIC MICE | Memory - drug effects | Amyloid beta-Peptides - pharmacology | Humans | 2-Amino-5-phosphonovalerate - pharmacology | Neuronal Plasticity - drug effects | Male | Peptide Fragments - pharmacology | Nicotinic Antagonists - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Dose-Response Relationship, Drug | Neuronal Plasticity - genetics | Mecamylamine - pharmacology | Receptors, Nicotinic - deficiency | Electric Stimulation - methods | Excitatory Postsynaptic Potentials - genetics | Synapses - drug effects | Mice, Inbred C57BL | Excitatory Amino Acid Antagonists - pharmacology | Hippocampus - cytology | Maze Learning - drug effects | Mice, Knockout | Patch-Clamp Techniques | Animals | Analysis of Variance | Mice | In Vitro Techniques | Bungarotoxins - pharmacology | alpha7 Nicotinic Acetylcholine Receptor | amyloid-β
Amyloid-β | α-7 nicotinic receptors | Alzheimer's disease | Memory | Hippocampus | Synaptic plasticity | alpha-7 nicotinic receptors | APP | memory | hippocampus | ALZHEIMERS-DISEASE | INTERSTITIAL FLUID | NICOTINIC ACETYLCHOLINE-RECEPTORS | NEUROSCIENCES | amyloid-beta | SECRETED FORMS | IN-VIVO | synaptic plasticity | PRECURSOR PROTEIN | SHORT-TERM | BRAIN | TRANSGENIC MICE | Memory - drug effects | Amyloid beta-Peptides - pharmacology | Humans | 2-Amino-5-phosphonovalerate - pharmacology | Neuronal Plasticity - drug effects | Male | Peptide Fragments - pharmacology | Nicotinic Antagonists - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Dose-Response Relationship, Drug | Neuronal Plasticity - genetics | Mecamylamine - pharmacology | Receptors, Nicotinic - deficiency | Electric Stimulation - methods | Excitatory Postsynaptic Potentials - genetics | Synapses - drug effects | Mice, Inbred C57BL | Excitatory Amino Acid Antagonists - pharmacology | Hippocampus - cytology | Maze Learning - drug effects | Mice, Knockout | Patch-Clamp Techniques | Animals | Analysis of Variance | Mice | In Vitro Techniques | Bungarotoxins - pharmacology | alpha7 Nicotinic Acetylcholine Receptor | amyloid-β
Journal Article
5.
Full Text
Preparation of tau oligomers after the protein extraction from bacteria and brain cortices
Methods in Molecular Biology, ISSN 1064-3745, 2018, Volume 1779, pp. 85 - 97
Oligomerization of soluble tau protein is attracting the attention of an increasingly larger number of scientists involved in research on Alzheimer's disease...
Tau extraction | Tau oligomerization | Affinity tag purification | Alzheimer’s disease | Fast protein liquid chromatography | Recombinant tau | Tauopathy | Bacteria - metabolism | Oxidation-Reduction | Humans | Protein Multimerization | Recombinant Proteins - chemistry | Chromatography, High Pressure Liquid | Cysteine - chemistry | tau Proteins - isolation & purification | Bacteria - genetics | tau Proteins - chemistry | Brain - metabolism | Recombinant Proteins - isolation & purification | Animals | Chromatography, Affinity | tau Proteins - genetics | Autopsy | Alzheimer Disease - metabolism | Mice
Tau extraction | Tau oligomerization | Affinity tag purification | Alzheimer’s disease | Fast protein liquid chromatography | Recombinant tau | Tauopathy | Bacteria - metabolism | Oxidation-Reduction | Humans | Protein Multimerization | Recombinant Proteins - chemistry | Chromatography, High Pressure Liquid | Cysteine - chemistry | tau Proteins - isolation & purification | Bacteria - genetics | tau Proteins - chemistry | Brain - metabolism | Recombinant Proteins - isolation & purification | Animals | Chromatography, Affinity | tau Proteins - genetics | Autopsy | Alzheimer Disease - metabolism | Mice
Journal Article
Sensors (Switzerland), ISSN 1424-8220, 03/2018, Volume 18, Issue 3, p. 792
The quality of the magnetic resonance spectroscopy (MRS) depends on the stability of magnetic resonance (MR) system performance and optimal hardware...
Magnetic resonance spectroscopy | Reproducibility | Change points detection | Quality control | Biomedical signal processing | ELECTROCHEMISTRY | CHEMISTRY, ANALYTICAL | quality control | PHANTOM | reproducibility | magnetic resonance spectroscopy | INSTRUMENTS & INSTRUMENTATION | SEQUENCE | biomedical signal processing | ASSURANCE | change points detection | MR SPECTROSCOPY | SPECTRA | BRAIN | Data points | Nuclear magnetic resonance--NMR | Computer simulation | Change detection | Time series | Spectra | Artifacts | Algorithms | Spectral resolution | Partitioning | Mathematical analysis | White noise | Software | Dynamic programming
Magnetic resonance spectroscopy | Reproducibility | Change points detection | Quality control | Biomedical signal processing | ELECTROCHEMISTRY | CHEMISTRY, ANALYTICAL | quality control | PHANTOM | reproducibility | magnetic resonance spectroscopy | INSTRUMENTS & INSTRUMENTATION | SEQUENCE | biomedical signal processing | ASSURANCE | change points detection | MR SPECTROSCOPY | SPECTRA | BRAIN | Data points | Nuclear magnetic resonance--NMR | Computer simulation | Change detection | Time series | Spectra | Artifacts | Algorithms | Spectral resolution | Partitioning | Mathematical analysis | White noise | Software | Dynamic programming
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e91954
Dynamin 1-3 isoforms are known to be involved in endocytotic processes occurring during synaptic transmission. No data has directly linked dynamins yet with...
TRANSMITTER RELEASE | RELEASE PROBABILITY | ISOFORMS | INHIBITION | AMYLOID-BETA | CALMODULIN | MULTIDISCIPLINARY SCIENCES | LONG-TERM POTENTIATION | ENDOCYTOSIS | SYNAPTIC PLASTICITY | MODULATION | Memory - drug effects | Memory Disorders - physiopathology | RNA, Small Interfering - genetics | Electric Stimulation | Refractory Period, Electrophysiological - physiology | Synaptic Transmission - physiology | Memory Disorders - metabolism | Neuronal Plasticity - drug effects | Male | Hippocampus - drug effects | Dynamin I - genetics | Excitatory Postsynaptic Potentials - drug effects | Excitatory Postsynaptic Potentials - physiology | Neuronal Plasticity - physiology | Long-Term Potentiation - drug effects | Long-Term Potentiation - physiology | Synaptic Transmission - drug effects | Refractory Period, Electrophysiological - drug effects | Synapses - drug effects | Gene Expression | Synapses - physiology | Mice, Inbred C57BL | Hydrazones - pharmacology | Animals | Dynamin I - metabolism | Mice | Hippocampus - physiology | Dynamin I - antagonists & inhibitors | Memory - physiology | Memory Disorders - chemically induced | RNA, Small Interfering - metabolism | Animal behavior | Hostages | Memory | Potentiation | Long-term potentiation | Fatigue | Stimulation | Pharmacology | siRNA | Proteins | Associative memory | Brain research | Plasticity (synaptic) | Synaptic transmission | Isoforms | Dynamin | Aging | Inhibition | Laboratory animals | Alzheimers disease | Hippocampus
TRANSMITTER RELEASE | RELEASE PROBABILITY | ISOFORMS | INHIBITION | AMYLOID-BETA | CALMODULIN | MULTIDISCIPLINARY SCIENCES | LONG-TERM POTENTIATION | ENDOCYTOSIS | SYNAPTIC PLASTICITY | MODULATION | Memory - drug effects | Memory Disorders - physiopathology | RNA, Small Interfering - genetics | Electric Stimulation | Refractory Period, Electrophysiological - physiology | Synaptic Transmission - physiology | Memory Disorders - metabolism | Neuronal Plasticity - drug effects | Male | Hippocampus - drug effects | Dynamin I - genetics | Excitatory Postsynaptic Potentials - drug effects | Excitatory Postsynaptic Potentials - physiology | Neuronal Plasticity - physiology | Long-Term Potentiation - drug effects | Long-Term Potentiation - physiology | Synaptic Transmission - drug effects | Refractory Period, Electrophysiological - drug effects | Synapses - drug effects | Gene Expression | Synapses - physiology | Mice, Inbred C57BL | Hydrazones - pharmacology | Animals | Dynamin I - metabolism | Mice | Hippocampus - physiology | Dynamin I - antagonists & inhibitors | Memory - physiology | Memory Disorders - chemically induced | RNA, Small Interfering - metabolism | Animal behavior | Hostages | Memory | Potentiation | Long-term potentiation | Fatigue | Stimulation | Pharmacology | siRNA | Proteins | Associative memory | Brain research | Plasticity (synaptic) | Synaptic transmission | Isoforms | Dynamin | Aging | Inhibition | Laboratory animals | Alzheimers disease | Hippocampus
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2017, Volume 12, Issue 12, p. e0189413
Soluble forms of oligomeric beta-amyloid (Aβ) are thought to play a central role in Alzheimer’s disease (AD). Transgenic manipulation of methylation of the...
Potentiation | Animal models | Traumatic brain injury | Peptides | Pathogenesis | Serine | Cognitive ability | Transgenic | Coffee | Phosphatase | Proteins | Rodents | Aging | Protected animals | Alzheimer's disease | Enzymes | Sensitivity analysis | Threonine | Neurodegenerative diseases | Pathological effects | Long-term potentiation | Pharmacology | Exposure | Apolipoproteins | Fear conditioning | Pathology | Sensitivity | Beans | Brain research | Animals | β-Amyloid | Mice | Protein phosphatase | Methylation | Molecular biology | Animal cognition
Potentiation | Animal models | Traumatic brain injury | Peptides | Pathogenesis | Serine | Cognitive ability | Transgenic | Coffee | Phosphatase | Proteins | Rodents | Aging | Protected animals | Alzheimer's disease | Enzymes | Sensitivity analysis | Threonine | Neurodegenerative diseases | Pathological effects | Long-term potentiation | Pharmacology | Exposure | Apolipoproteins | Fear conditioning | Pathology | Sensitivity | Beans | Brain research | Animals | β-Amyloid | Mice | Protein phosphatase | Methylation | Molecular biology | Animal cognition
Journal Article
AIP Conference Proceedings, ISSN 0094-243X, 07/2017, Volume 1863, Issue 1
Medical centres are obliged to store past medical records, including the results of quality assurance (QA) tests of the medical equipment, which is especially...
magnetic resonance spectroscopy | time series | change point detection | quality control | reproducibility | Medical equipment | Medical centres | Medical devices | Quality assurance | Nuclear magnetic resonance--NMR | Reproducibility | Quality control | Medical electronics | Singular value decomposition
magnetic resonance spectroscopy | time series | change point detection | quality control | reproducibility | Medical equipment | Medical centres | Medical devices | Quality assurance | Nuclear magnetic resonance--NMR | Reproducibility | Quality control | Medical electronics | Singular value decomposition
Journal Article
Scientific Reports, ISSN 2045-2322, 05/2015, Volume 5, Issue 1, p. 10730
Small ubiquitin-like modifier-1 (SUMO1) plays a number of roles in cellular events and recent evidence has given momentum for its contributions to neuronal...
RAT HIPPOCAMPAL-NEURONS | MORPHOGENESIS | PROTEIN SUMOYLATION | ROLES | PHOSPHORYLATION | AMYLOID-BETA | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | NEURODEGENERATION | MICE | PLASTICITY | Sumoylation - genetics | Synaptic Transmission - genetics | Cells, Cultured | Mice, Transgenic | Brain - growth & development | Brain - metabolism | Animals | SUMO-1 Protein - genetics | Synaptotagmin I - metabolism | Proteomics | Mice | Neurons - metabolism | SUMO-1 Protein - metabolism | Ubiquitin | Immunoprecipitation | Spine | Memory | Transgenic mice | Synaptic density | Molecular weight | SUMO protein | Proteins | Learning | Synaptic transmission | Neurodegeneration | Rodents | Cytoskeleton | Synaptotagmin | Age
RAT HIPPOCAMPAL-NEURONS | MORPHOGENESIS | PROTEIN SUMOYLATION | ROLES | PHOSPHORYLATION | AMYLOID-BETA | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | NEURODEGENERATION | MICE | PLASTICITY | Sumoylation - genetics | Synaptic Transmission - genetics | Cells, Cultured | Mice, Transgenic | Brain - growth & development | Brain - metabolism | Animals | SUMO-1 Protein - genetics | Synaptotagmin I - metabolism | Proteomics | Mice | Neurons - metabolism | SUMO-1 Protein - metabolism | Ubiquitin | Immunoprecipitation | Spine | Memory | Transgenic mice | Synaptic density | Molecular weight | SUMO protein | Proteins | Learning | Synaptic transmission | Neurodegeneration | Rodents | Cytoskeleton | Synaptotagmin | Age
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2016, Volume 113, Issue 12, pp. 3347 - 3352
Elevated levels of the β-amyloid peptide (Aβ) are thought to contribute to cognitive and behavioral impairments observed in Alzheimer’s disease (AD). Protein...
Methylation | Alzheimer's disease | Cognitive impairment | Protein phosphatase 2A | β-amyloid | TAU-PROTEIN | CATALYTIC SUBUNIT | METHYLTRANSFERASE | PHOSPHOPROTEIN PHOSPHATASE 2A | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | SYNAPTIC PLASTICITY | beta-amyloid | IN-VITRO | protein phosphatase 2A | methylation | cognitive impairment | PRECURSOR PROTEIN | CARBOXYL METHYLATION | Behavior, Animal | Amyloid beta-Peptides - physiology | Cognition Disorders - physiopathology | Animals | Protein Phosphatase 2 - metabolism | Mice, Transgenic | Mice | Biological Sciences
Methylation | Alzheimer's disease | Cognitive impairment | Protein phosphatase 2A | β-amyloid | TAU-PROTEIN | CATALYTIC SUBUNIT | METHYLTRANSFERASE | PHOSPHOPROTEIN PHOSPHATASE 2A | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | DOWN-REGULATION | SYNAPTIC PLASTICITY | beta-amyloid | IN-VITRO | protein phosphatase 2A | methylation | cognitive impairment | PRECURSOR PROTEIN | CARBOXYL METHYLATION | Behavior, Animal | Amyloid beta-Peptides - physiology | Cognition Disorders - physiopathology | Animals | Protein Phosphatase 2 - metabolism | Mice, Transgenic | Mice | Biological Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66226
Serine-threonine protein kinases are critical to CNS function, yet there is a dearth of highly selective, CNS-active kinase inhibitors for in vivo...
POTENT | ACTIVATION | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | BEHAVIORAL DEFICITS | MOUSE MODEL | P38-ALPHA MAPK | CYTOKINE UP-REGULATION | INHIBITORS | BINDING | DISCOVERY | Mitogen-Activated Protein Kinase 14 - antagonists & inhibitors | Peptide Fragments - toxicity | Pyridines - chemistry | Humans | Brain - enzymology | Male | Pyridazines - pharmacology | Pyridazines - chemical synthesis | Brain - metabolism | Protein Kinase Inhibitors - chemistry | Long-Term Potentiation - drug effects | Drug Design | Mitogen-Activated Protein Kinase 14 - chemistry | Cell Line | Protein Kinase Inhibitors - chemical synthesis | Catalytic Domain | Amyloid beta-Peptides - toxicity | Mice, Inbred C57BL | Pyridines - chemical synthesis | Models, Molecular | Pyridazines - chemistry | Brain - drug effects | Animals | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Development and progression | Nervous system diseases | Cognition disorders | Protein kinases | Analysis | G protein-coupled receptors | Target recognition | Disease | Serine | Central nervous system | Cognitive ability | Activation | Biology | Selectivity | Catalytic activity | Kinases | Crystallography | Neuronal-glial interactions | Proteins | Cascades | Modulation | Aging | Catalysis | Probes | Alzheimer's disease | Cytokines | Threonine | Neurodegenerative diseases | Pharmacology | Mammals | Screens | Studies | Pathology | Signaling | Chemistry | Inhibitors | Protein kinase | β-Amyloid | In vivo methods and tests
POTENT | ACTIVATION | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | BEHAVIORAL DEFICITS | MOUSE MODEL | P38-ALPHA MAPK | CYTOKINE UP-REGULATION | INHIBITORS | BINDING | DISCOVERY | Mitogen-Activated Protein Kinase 14 - antagonists & inhibitors | Peptide Fragments - toxicity | Pyridines - chemistry | Humans | Brain - enzymology | Male | Pyridazines - pharmacology | Pyridazines - chemical synthesis | Brain - metabolism | Protein Kinase Inhibitors - chemistry | Long-Term Potentiation - drug effects | Drug Design | Mitogen-Activated Protein Kinase 14 - chemistry | Cell Line | Protein Kinase Inhibitors - chemical synthesis | Catalytic Domain | Amyloid beta-Peptides - toxicity | Mice, Inbred C57BL | Pyridines - chemical synthesis | Models, Molecular | Pyridazines - chemistry | Brain - drug effects | Animals | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Development and progression | Nervous system diseases | Cognition disorders | Protein kinases | Analysis | G protein-coupled receptors | Target recognition | Disease | Serine | Central nervous system | Cognitive ability | Activation | Biology | Selectivity | Catalytic activity | Kinases | Crystallography | Neuronal-glial interactions | Proteins | Cascades | Modulation | Aging | Catalysis | Probes | Alzheimer's disease | Cytokines | Threonine | Neurodegenerative diseases | Pharmacology | Mammals | Screens | Studies | Pathology | Signaling | Chemistry | Inhibitors | Protein kinase | β-Amyloid | In vivo methods and tests
Journal Article
PLOS ONE, ISSN 1932-6203, 12/2017, Volume 12, Issue 12, p. e0189413
Soluble forms of oligomeric beta-amyloid (A beta) are thought to play a central role in Alzheimer's disease (AD). Transgenic manipulation of methylation of the...
TAU HYPERPHOSPHORYLATION | METHYLATION | MEMORY | MULTIDISCIPLINARY SCIENCES | A-BETA | INJURY | SODIUM SELENATE | E-BASED PEPTIDE | PROTEIN PHOSPHATASE 2A | SYNAPTIC PLASTICITY | APOLIPOPROTEIN-E | Phosphorylation | Electrophysiology | Male | Coffee | Serotonin - pharmacology | Alzheimer Disease - pathology | Cognition Disorders - prevention & control | Female | Disease Models, Animal | Nervous System Diseases - pathology | Mice, Inbred C57BL | Nervous System Diseases - drug therapy | Solubility | Alzheimer Disease - drug therapy | Cognition - drug effects | Fear | Animals | Maze Learning | Conditioning (Psychology) | Neuronal Plasticity | Long-Term Potentiation | Serotonin - analogs & derivatives | Mice | Amyloid beta-Peptides - chemistry | Methylation | Prevention | Usage | Dietary supplements | Amyloid beta-protein | Cognition disorders | Research | Alzheimer's disease
TAU HYPERPHOSPHORYLATION | METHYLATION | MEMORY | MULTIDISCIPLINARY SCIENCES | A-BETA | INJURY | SODIUM SELENATE | E-BASED PEPTIDE | PROTEIN PHOSPHATASE 2A | SYNAPTIC PLASTICITY | APOLIPOPROTEIN-E | Phosphorylation | Electrophysiology | Male | Coffee | Serotonin - pharmacology | Alzheimer Disease - pathology | Cognition Disorders - prevention & control | Female | Disease Models, Animal | Nervous System Diseases - pathology | Mice, Inbred C57BL | Nervous System Diseases - drug therapy | Solubility | Alzheimer Disease - drug therapy | Cognition - drug effects | Fear | Animals | Maze Learning | Conditioning (Psychology) | Neuronal Plasticity | Long-Term Potentiation | Serotonin - analogs & derivatives | Mice | Amyloid beta-Peptides - chemistry | Methylation | Prevention | Usage | Dietary supplements | Amyloid beta-protein | Cognition disorders | Research | Alzheimer's disease
Journal Article
European Polymer Journal, ISSN 0014-3057, 10/2018, Volume 107, pp. 189 - 201
Nanocomposites based on poly(ethylene terephthalate-ethylene dilinoleate) (PET-DLA) copolymers of different hard to soft segment ratios (40:60 and 60:40) and...
Carbon nanotubes | Thermoplastic elastomers | Carbon black | Heart assist device | Nanocomposites | Graphene | POLYMER SCIENCE | POLY(ETHYLENE-TEREPHTHALATE) | Biological products | Analysis | Graphite | Elastomers | Nanotubes | Mechanical properties | Polymerization | Nuclear magnetic resonance spectroscopy
Carbon nanotubes | Thermoplastic elastomers | Carbon black | Heart assist device | Nanocomposites | Graphene | POLYMER SCIENCE | POLY(ETHYLENE-TEREPHTHALATE) | Biological products | Analysis | Graphite | Elastomers | Nanotubes | Mechanical properties | Polymerization | Nuclear magnetic resonance spectroscopy
Journal Article
Annals of Neurology, ISSN 0364-5134, 05/2011, Volume 69, Issue 5, pp. 819 - 830
Objective: The goal of this study was to investigate the role of endogenous amyloid‐β peptide (Aβ) in healthy brain. Methods: Long‐term potentiation (LTP), a...
CA1 REGION | ALZHEIMERS-DISEASE | IN-VIVO | NICOTINIC ACETYLCHOLINE-RECEPTOR | PRECURSOR-PROTEIN | PROTEIN-DEFICIENT MICE | RAT HIPPOCAMPUS | SPATIAL MEMORY | LONG-TERM POTENTIATION | NEUROSCIENCES | CLINICAL NEUROLOGY | COGNITIVE DEFICITS | Enzyme-Linked Immunosorbent Assay - methods | Memory - drug effects | Humans | Male | Hippocampus - drug effects | Long-Term Potentiation - drug effects | Amyloid beta-Peptides - genetics | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Long-Term Potentiation - physiology | Behavior, Animal - drug effects | Electric Stimulation - methods | Peptide Fragments - metabolism | Mice, Inbred C57BL | RNA, Small Interfering - pharmacology | Gene Expression Regulation - physiology | Maze Learning - drug effects | Antibodies - pharmacology | Amyloid beta-Protein Precursor - genetics | Animals | Amyloid beta-Peptides - immunology | Mice | Biophysics - methods | Hippocampus - physiology | Memory - physiology
CA1 REGION | ALZHEIMERS-DISEASE | IN-VIVO | NICOTINIC ACETYLCHOLINE-RECEPTOR | PRECURSOR-PROTEIN | PROTEIN-DEFICIENT MICE | RAT HIPPOCAMPUS | SPATIAL MEMORY | LONG-TERM POTENTIATION | NEUROSCIENCES | CLINICAL NEUROLOGY | COGNITIVE DEFICITS | Enzyme-Linked Immunosorbent Assay - methods | Memory - drug effects | Humans | Male | Hippocampus - drug effects | Long-Term Potentiation - drug effects | Amyloid beta-Peptides - genetics | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Long-Term Potentiation - physiology | Behavior, Animal - drug effects | Electric Stimulation - methods | Peptide Fragments - metabolism | Mice, Inbred C57BL | RNA, Small Interfering - pharmacology | Gene Expression Regulation - physiology | Maze Learning - drug effects | Antibodies - pharmacology | Amyloid beta-Protein Precursor - genetics | Animals | Amyloid beta-Peptides - immunology | Mice | Biophysics - methods | Hippocampus - physiology | Memory - physiology
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2009, Volume 29, Issue 25, pp. 8075 - 8086
Memory loss, synaptic dysfunction, and accumulation of amyloid beta-peptides (A beta) are major hallmarks of Alzheimer's disease (AD). Downregulation of the...
NEURONAL GENES | SILDENAFIL | AVOIDANCE | SELECTIVE PDE5 INHIBITOR | NITRIC-OXIDE | CGMP | RAT HIPPOCAMPUS | MICE | MECHANISMS | DYSFUNCTION | NEUROSCIENCES | Immunohistochemistry | Memory - drug effects | Piperazines - administration & dosage | Phosphodiesterase 5 Inhibitors | Purines - administration & dosage | Sulfones - pharmacology | Sildenafil Citrate | Time Factors | Amyloid beta-Peptides - metabolism | Polymerase Chain Reaction | Spatial Behavior - drug effects | Synaptic Transmission - drug effects | Phosphorylation - drug effects | Piperazines - pharmacokinetics | Alzheimer Disease - psychology | Disease Models, Animal | Psychomotor Performance | Conditioning, Classical - drug effects | Phosphodiesterase Inhibitors - pharmacokinetics | Purines - pharmacology | Purines - pharmacokinetics | Injections, Intraperitoneal | Alzheimer Disease - drug therapy | Phosphodiesterase Inhibitors - pharmacology | Mice, Transgenic | Treatment Outcome | Sulfones - pharmacokinetics | Piperazines - pharmacology | Neuropsychological Tests | Phosphodiesterase Inhibitors - administration & dosage | Amyloid beta-Protein Precursor - genetics | Animals | Analysis of Variance | Cyclic GMP - metabolism | Alzheimer Disease - metabolism | Cyclic AMP Response Element-Binding Protein - metabolism | Mice | Mutation | Sulfones - administration & dosage
NEURONAL GENES | SILDENAFIL | AVOIDANCE | SELECTIVE PDE5 INHIBITOR | NITRIC-OXIDE | CGMP | RAT HIPPOCAMPUS | MICE | MECHANISMS | DYSFUNCTION | NEUROSCIENCES | Immunohistochemistry | Memory - drug effects | Piperazines - administration & dosage | Phosphodiesterase 5 Inhibitors | Purines - administration & dosage | Sulfones - pharmacology | Sildenafil Citrate | Time Factors | Amyloid beta-Peptides - metabolism | Polymerase Chain Reaction | Spatial Behavior - drug effects | Synaptic Transmission - drug effects | Phosphorylation - drug effects | Piperazines - pharmacokinetics | Alzheimer Disease - psychology | Disease Models, Animal | Psychomotor Performance | Conditioning, Classical - drug effects | Phosphodiesterase Inhibitors - pharmacokinetics | Purines - pharmacology | Purines - pharmacokinetics | Injections, Intraperitoneal | Alzheimer Disease - drug therapy | Phosphodiesterase Inhibitors - pharmacology | Mice, Transgenic | Treatment Outcome | Sulfones - pharmacokinetics | Piperazines - pharmacology | Neuropsychological Tests | Phosphodiesterase Inhibitors - administration & dosage | Amyloid beta-Protein Precursor - genetics | Animals | Analysis of Variance | Cyclic GMP - metabolism | Alzheimer Disease - metabolism | Cyclic AMP Response Element-Binding Protein - metabolism | Mice | Mutation | Sulfones - administration & dosage
Journal Article